Industry Supported Sessions

​​​​​​​​​​

THURSDAY, 25 JUNE​ 2015

Supportive Care Strategies: Bridging the Gap Between Guidelines and Clinical Practice
Industry Symposium Supported by Teva
14:15 – 15:45
Auditorium 10/11

14:15 – 14:30​Welcome and Introduction
Supportive care in cancer: where are we today? 
Bryan Hennessy, Ireland
14:30 – 14:50ESA in Chemotherapy-induced Anemia: Optimising Treatment 
Heinz Ludwig, Austria
14:50 – 15:10Advances in Managing Chemotherapy-induced Neutropenia
Hartmut  Link, Germany
15:10 – 15:30​Opioids and Breakthrough Cancer Pain (BTCP): Strategies to Improve Quality of Life 
Giovanni Rosti, Italy
15:30 – 15:45Q&A and Closing Remarks 
Bryan​ Hennessy, Ireland


 
NK1 Pathway 10 years and Counting – Current & Future State…
Industry Symposium Supported by MSD
14:15 – 15:45
Auditorium​ 15​

​14:15 – 14:25Welcome & Introductions - Richard Gralla
14:25 – 14:50What We Have Learned! - Richard Gralla
14:50 – 15:15Current State – Karin Jordan
15:15 – 15:40Future State - Can we move from knowledge to action? - David Warr​
15:40 – 15:45​Closing​

 


Almost There! Winning the Battle Against Chemotherapy-Induced Nausea
and Vomiting
Industry Symposium Supported by Tesaro
17:30 – 19:00
Auditorium 10/11

17:30 – 17:40Welcome and "Beat the Experts" quiz on chemotherapy-induced nausea and vomiting (CINV) Jørn Herrstedt, MD
17:40 – 18:00The physiology of emesis: Why do we need combination strategies to minimize CINV? Richard Gralla, MD, FACP
18:00 – 18:05Questions
18:05 – 18:25Applying the available guidelines for CINV into clinical practice Matti Aapro, MD
18:25 – 18:30Questions
18:30 – 18:50​Getting ever closer to reliable control of vomiting and nausea associated ​with emetogeni​c chemotherapy ​
Bernardo Rapoport, MD
18:50 – 18:55Questions
18:55 – 19:00prIME PointsTM​​ - Jørn Herrstedt, MD


FRIDAY, JUNE​ 26, 2015​


Meet your Expert Session
​The Challenges of Opioid-Induced Constipation in Supportive Care
Industry Session Supported by AstraZeneca
08:00 – 08:45
​​Meeting Room 19


08:00 – 08:03Introduction - Søren Søfelt, Denmark
​08:03 – 08:28Opioid-induced constipation, the patient burden and management: Ulf K​ongsgaard, Norway
08:28-08:43Discussion
08:43 - 08:45Closure - Søren Søfelt, Denmark


Helsinn Sponsored session.jpg 


Raising the bar in supportive care: treating nausea in cancer patients

Industry Symposium Supported by Helsinn
12:45-14:15
Auditorium 10/11​


12:45–12:50Welcome and introductio
M. Aapro (Switzerland)
12:50–13:10Understanding the physiology of nausea: foundation of care R. Gralla (USA)
13:10–13:30Current therapies of treatment-induced nausea and vomiting: the building blocks of care K. Jordan (Germany)
13:30–13:50Beyond CINV: multifactorial aspects of nausea and vomiting 
A. Molassiotis (Hong Kong)
13:50-14:10Panel discussion
14:10-14:15Summary and closing


Optimising Contemporary Cancer Treatment Through Effective Use of Biosimilars
Industry Symposium Supported by Hospira
16:30 - 17:30
​​Auditorium 10/​11​

​16:30 – 16:35​​Welcome and Objective
George 
Rodgers
16:35 – 16:55Biosimilars' Impact in Cancer Supportive Care and the Roadmap for the Future
• Rationale for biosimilars
• Overall cancer care and the impact of biosimilar treatment options
• Enhancing the utility of biosimilars to increase overall value​
 Speaker: ​Paul Cornes​​
16:55 – 17:15The European Biosimilar Experience in Supportive Cancer ​Care
• Real-world experience with biosimilars
• What have we learned? Observational study results on efficacy and safety​​• Practical considerations in biosimilar application
​Speaker: Matti Aapro​
17:15 – 17:​25Discussion/Q&A
All fac
ulty
17:25 – 17:30Summary and Close
George Rodgers​


 ​​

Keep Me Updated